Pyrexia, commonly known as fever, is a clinical symptom frequently encountered in medical practice. It is a physiological response to a variety of conditions, most commonly infectious diseases. Understanding the pathophysiology, identifying the cause, and managing fever effectively are critical to patient care.
Pyrexia is the body's adaptive response to pathologic conditions, primarily infections. The hypothalamus, acting as the body's thermostat, raises the set-point temperature in response to pyrogens. These can be endogenous, such as cytokines, or exogenous like microbial toxins. This results in the characteristic symptoms of fever.
Identifying the cause of pyrexia is crucial for targeted treatment. A detailed history and physical examination often provide valuable clues. Laboratory tests, including complete blood count, cultures, and imaging studies, may be necessary in some cases. Infections are the most common cause, but non-infectious causes such as malignancies, autoimmune diseases, and drug reactions should also be considered.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, are commonly used for symptomatic relief. However, their use should be balanced against potential side effects. In cases where the cause of fever is unclear, empirical antimicrobial therapy may be initiated while investigations are ongoing.
Management of pyrexia may differ in special populations, such as children, pregnant women, and immunocompromised patients. In these groups, the risk of serious infections is higher, and a more cautious approach is often warranted. Additionally, the choice of antipyretics may be limited due to safety concerns.
Pyrexia is a common clinical symptom with a wide range of causes. A systematic approach to identifying the cause and managing the fever effectively is essential. Further research is needed to refine our understanding of the pathophysiology of fever and to develop more effective antipyretic therapies.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation